Evidence map›Paper›PMID 40539440›Full record

ArticleMolecular medicine reports2025

Yin Yuan, Xiaojing Liu, Tian Zhou, Zhongguang Zhou, Minghai Gong, Yihang Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yin YuanTesting Center, Yunnan Branch, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Xishuangbanna Dai Autonomous Prefecture, Yunnan 666100, P.R. China.
Xiaojing LiuDepartment of Rehabilitation and Tuina, Liu Xin Sinew and Bone Health Center, Aksu, Xinjiang Uygur Autonomous Region 843003, P.R. China.
Tian ZhouCollege of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China.
Zhongguang ZhouCollege of Medicine, Tarim University, Alar, Xinjiang Uygur Autonomous Region 843300, P.R. China.
Minghai GongCollege of Medicine, Tarim University, Alar, Xinjiang Uygur Autonomous Region 843300, P.R. China.
Yihang LiTesting Center, Yunnan Branch, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Xishuangbanna Dai Autonomous Prefecture, Yunnan 666100, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis (LF) is a liver condition that represents a serious health risk to humans, and effective therapeutic options are limited.

Indexed as

CollagenLiver CirrhosisPolygonatumPolysaccharidesSignal TransductionSmad ProteinsTransforming Growth Factor betaAnimalsDisease Models, AnimalLiverMaleOxidative StressRatsRats, Sprague-DawleyCollagenPolysaccharidesSmad ProteinsTransforming Growth Factor betacollagenliver fibrosisPolygonatum sibiricum polysaccharideratsTGF‑β/Smad signaling pathway

Identifiers

PMID40539440
PMCPMC12215250

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.